AzTrials
AzTrials

ObesityDissobeNCT05081778

Dissociative Disorders in Obesity (Dissobe)

An observational study of Obesity and Dissociative Disorder, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

THe aim of this study is to determine the frequency of dissociative tendencies in the obese population treated at the CELIOBE (Liberal Center for Obesity Support) at Hôpital Privé La Louvière among patients consulting for the first time and looking for a medical or surgical course. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Obesity, Dissociative Disorder
What is being tested?
Obese patient following a medical course
How many people
240 participants
Where
1 siteFrance
Study dates
5 May 2019to 5 Dec 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Obese population with a body mass index over 30kg/m2 Minimum age : 18 years-old Patients consulting for the first time at CELIOBE and wishing a medical or surgical course.

Who may be able to join

  • Age over 18
  • Obesity defined by a Body Mass Index (BMI) ≥ 30 kg / m2
  • Patient seen in consultation at CELIOBE for the first time for the management of an overweight problem, wishing for surgical or medical care
  • Patient having been informed and not opposing to this research
  • Patient affiliated or beneficiary of a social security scheme

Who cannot join

  • Psychotic antecedents: Schizophrenia, Schizoaffective disorders, Hallucinatory psychoses, Brief psychotic attacks
  • Addictive behaviors (alcohol, drug addiction)
  • Drug use
  • Taking antipsychotics and mood stabilizers
  • Dissociative identity disorders proven
  • Bipolar disorders or severe mental illness
Show all 9Show fewer
  • Understanding troubles
  • Protected patient: Major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; Hospitalized without consent
  • Pregnant, breastfeeding or parturient woman

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital privé La Louvière

    Lille, Haut de France, 59800

Other trials in France

About this study

Official title: Dissociative Disorders in Obesity

THe aim of this study is to determine the frequency of dissociative tendencies in the obese population treated at the CELIOBE (Liberal Center for Obesity Support) at Hôpital Privé La Louvière among patients consulting for the first time and looking for a medical or surgical course. The DES scale of Carlson and Putman will be used.

Being tested
Obese patient following a medical course
Medical subject headings
Obesity, Dissociative Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Obese patient following a medical courseBehavioural

    Questionnaires for the assessment of dissociative disorders in obese patients : DES scale of Carlson and Putman, SDQ-20 of Nijenhuis, comorbidities, Dutch Eating Behaviour Questionnaire (DEBQ), questionnaire of Rosenberg

Study groups in NCT05081778
Study groupRoleWhat they receive
Obese patient following a medical courseNot described
Receives: Behavioral: Obese patient following a medical course
Obese patient following a surgical courseNot described
Receives: Behavioral: Obese patient following a medical course

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The degree of dissociative tendencies

    The degree of dissociative tendencies measured by the Carlson and Putman DES scale. Score from 0 to 100. Patients with a DES score of 25 or higher are more likely to have a dissociative disorder

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Oct 2021
  2. Study start5 May 2019
  3. Primary completion5 Jul 2019
  4. Study completion5 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
240 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05081778
Sponsor's protocol ID
2018-A02797-48
Acronym
Dissobe
Status last verified
Jul 2026
First submitted
4 Oct 2021
Last updated
17 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Obesity and Dissociative Disorder, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The degree of dissociative tendencies (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in